Arvind Kumar, MD
Board Certifications: Internal Medicine and Medical Oncology
Languages: English, Hindi and Magahi
Locations: Edison, NJ
Call Edison, NJ (908) 755-1165
With more than 25 years of experience in the medical field, Dr. Arvind Kumar is in private practice in Edison, N.J. and board certified in Internal Medicine as well as Medical Oncology.
He completed his residency at Jersey Shore Medical Center and did his fellowship at Maimonides Medical Center in Brooklyn, N.Y. He is past chairman of the Medical Oncology Department at JFK Medical Center and has taught in the medical residency program at Muhlenberg Hospital and Raritan Bay Medical Centers. He has lectured extensively on a variety of subjects related to medical oncology both in the United States and abroad. Very involved in philanthropy, Dr. Kumar supports health care and educational endeavors for underserved populations in both the United States and in India.
Academic Appointments and Achievements
Awards and Honors
NJ Top Doctors – Oncology
Previous Chair of Medical Oncology at JFK Medical Center
Professional Memberships
American Society of Clinical Oncology
American Medical Association
Education
Medical Education
Masters in Electrical Engineering, New York University
Doctor of Medicine, Universidad Central del Este, Dominican Republic
Residency
Jersey Shore Medical Center
Fellowship
Oncology at Maimonides Medical Center, Brooklyn, N.Y.
Locations
Patients may schedule appointments with Dr Kumar at:
Hospital Affiliations
Hackensack Meridian Health JFK Medical Center, Edison, N.J.
Robert Wood Johnson University Hospital, Rahway, N.J.
We are here for you
For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.